<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43927">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02534454</url>
  </required_header>
  <id_info>
    <org_study_id>20547</org_study_id>
    <secondary_id>R21DA037546</secondary_id>
    <nct_id>NCT02534454</nct_id>
  </id_info>
  <brief_title>TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence</brief_title>
  <acronym>TDCSNIC</acronym>
  <official_title>Transcranial Direct Current Stimulation (TDCS) and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Mind Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The Mind Research Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the phase 1 translational pilot study proposed here is to gather preliminary
      data investigating the efficacy of transcranial direct current stimulation (TDCS) and
      cognitive retraining to enhance nicotine replacement therapy for smoking cessation. The
      recent use of TDCS over task relevant regions to alter behavior holds incredible promise for
      use in cognitive retraining intervention protocols. Previous studies of cognitive retraining
      have focused on implicit training techniques. This proposed study will attempt to enhance
      these implicit training techniques through the use of TDCS during implicit retraining in
      order to increase learning of avoidance-related action tendencies towards tobacco. The
      objective of this pilot study is to establish the feasibility and obtain preliminary data on
      the effectiveness of using brain stimulation with cognitive retraining to reduce cigarette
      smoking in individuals with nicotine addiction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cigarettes per Smoking Day</measure>
    <time_frame>11-Weeks Post-transcranial direct current stimulation (TDCS)/Retraining</time_frame>
    <description>Number of cigarettes consumed per day will be assessed using the Timeline Follow-back method to obtain the number of cigarettes consumed on each day since the last administration of the Timeline Follow-back. Cigarettes per smoking day will be the mean number of cigarettes consumed on days on which cigarettes were consumed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Approach Bias Towards Cigarettes (Measure of response time differences)</measure>
    <time_frame>1 week Post-transcranial direct current stimulation (TDCS)/Retraining</time_frame>
    <description>Measure of response time differences to push vs. pull a joystick in response to pictures of cigarettes vs. control objects (e.g. pens)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Nicotine Dependence</condition>
  <arm_group>
    <arm_group_label>Active TDCS + Active Retraining</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.0 milliamperes (mA) of transcranial direct current stimulation (TDCS) applied during active nicotine avoidance retraining</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham TDCS + Active Retraining</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.1 mA of transcranial direct current stimulation (TDCS) applied during active nicotine avoidance retraining</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active TDCS + Sham retraining</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2.0 mA of transcranial direct current stimulation (TDCS) applied during sham nicotine avoidance retraining</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham TDCS + Sham Retraining</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.1 mA of transcranial direct current stimulation (TDCS) applied during sham nicotine avoidance retraining</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active Retraining</intervention_name>
    <arm_group_label>Active TDCS + Active Retraining</arm_group_label>
    <arm_group_label>Sham TDCS + Active Retraining</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Sham Retraining</intervention_name>
    <arm_group_label>Active TDCS + Sham retraining</arm_group_label>
    <arm_group_label>Sham TDCS + Sham Retraining</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active transcranial direct current stimulation (TDCS)</intervention_name>
    <arm_group_label>Active TDCS + Active Retraining</arm_group_label>
    <arm_group_label>Active TDCS + Sham retraining</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham transcranial direct current stimulation (TDCS)</intervention_name>
    <arm_group_label>Sham TDCS + Active Retraining</arm_group_label>
    <arm_group_label>Sham TDCS + Sham Retraining</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Replacement Therapy (Habitrol)</intervention_name>
    <description>Administration of Nicotine Replacement Therapy Patches</description>
    <arm_group_label>Active TDCS + Active Retraining</arm_group_label>
    <arm_group_label>Sham TDCS + Active Retraining</arm_group_label>
    <arm_group_label>Active TDCS + Sham retraining</arm_group_label>
    <arm_group_label>Sham TDCS + Sham Retraining</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consume 10 or more cigarettes/day average for the past 60 days

          -  Able to provide informed consent

          -  Less than 3 months smoking abstinence in the past year

          -  Right Handed

        Exclusion Criteria:

          -  Serious medical illness within 6 months (e.g. cancer, hepatic, or renal disease)

          -  Significant cardiovascular disease (e.g. recent stroke or heart attack, arrhythmias,
             worsening angina pectoris, uncontrolled hypertension) generalized skin disorders, or
             sensitivity to the nicotine patch

          -  Use of illicit drugs (excluding marijuana) in the previous 30 days

          -  Psychosis, psychotic disorder, or bipolar disorder

          -  Current active major depression (depressive episode within last month)

          -  Clinically significant suicidal ideation

          -  Prior seizure

          -  Current bupropion or tricyclic antidepressants

          -  Current pregnancy, trying to become pregnant, or breastfeeding

          -  Current active alcohol dependence (symptoms in last 30 days)

          -  Left-handedness

          -  Current medication known to interact with nicotine replacement therapy (NRT) or
             smoking cessation (e.g. adenosine, cimetidine, conivaptan, cyproterone, peginterferon
             alfa-2bg, tocilizumab, theophylline)

          -  Metal in the head

          -  Implanted brain medical devices

          -  Electromedical devices

          -  Latex Allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eric D Claus, PhD</last_name>
    <phone>505-272-5028</phone>
    <email>eclaus@mrn.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan D Klimaj, BS</last_name>
    <phone>505-272-5028</phone>
    <email>sklimaj@mrn.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Mind Research Network</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jody Roberts, MS</last_name>
      <phone>505-272-5028</phone>
      <email>jroberts@mrn.org</email>
    </contact>
    <contact_backup>
      <last_name>Jessica Mickey, BA</last_name>
      <phone>505-272-5028</phone>
      <email>jmickey@mrn.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 14, 2016</lastchanged_date>
  <firstreceived_date>August 24, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
